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http://dx.doi.org/10.1016/j.stemcr.2017.08.008SUMMARYDefects in neural crest development have been implicated in many human disorders, but information about human neural crest forma-
tion mostly depends on extrapolation from model organisms. Human pluripotent stem cells (hPSCs) can be differentiated into in vitro
counterparts of the neural crest, and some of the signals known to induce neural crest formation in vivo are required during this process.
However, the protocols in current use tend to produce variable results, and there is no consensus as to the precise signals required for
optimal neural crest differentiation. Using a fully defined culture system, we have now found that the efficient differentiation of hPSCs
to neural crest depends on precise levels of BMP signaling, which are vulnerable to fluctuations in endogenous BMP production. We pre-
sent a method that controls for this phenomenon and could be applied to other systems where endogenous signaling can also affect the
outcome of differentiation protocols.INTRODUCTION
Neural crest, a transient, migratory tissue arising during
vertebrate development, is first observed in the human at
Carnegie stage 9 (O’Rahilly and Mu¨ller, 2007). Defects in
the development of the tissue can lead to neurocristopa-
thies with a wide range of characteristics. For ethical
reasons, the study of human neural crest induction, and
human ectoderm development in general, has been largely
restricted to observational work with human embryos (Bet-
ters et al., 2010; O’Rahilly and Mu¨ller, 2007) and to studies
of in vitro differentiation of human pluripotent stem cells
(hPSCs). The latter have been carried out to generate neural
(Chambers et al., 2009), neural crest (Menendez et al.,
2011; Mica et al., 2013; Leung et al., 2016), placodal
(Chen et al., 2012), and non-neural ectoderm (Metallo
et al., 2010) lineages. In vivo, human neural crest expresses
many of the markers found in other vertebrates, including
SOX10, PAX3, TFAP2a, and p75 (Betters et al., 2010), and
when hPSCs are differentiated into neural crest they share
this expression profile and can generate neural crest-
derived lineages in vitro (Menendez et al., 2011; Mica
et al., 2013). Systems such as these not only hold potential
for developing an understanding of neural crest formation
in humans but also for generating cells for the treatment of
neurocristopathy.
In vertebrate ectoderm, BMP signaling proteins play a
key role inmedio-lateral patterning. Neural crest induction
in avians and amphibians, whichwas originally thought to
occur through a process of interaction between neurecto-
derm and the developing epidermis (Selleck and Bronner-Stem
This is an open access artiFraser, 1995), is now understood to occur during gastrula-
tion in a manner dependent on BMP, as well as other sig-
nals (Basch et al., 2006). Antagonists produced by the dor-
sal mesoderm modulate BMP activity across the ectoderm
differentially specifying neural, neural crest, placodal,
and epidermal lineages (Hemmati-Brivanlou et al., 1994;
Furthauer et al., 1999; Zimmerman et al., 1996; Sasai
et al., 1996; Piccolo et al., 1996; Lamb et al., 1993). These
antagonists generate the intermediate levels of BMP activ-
ity required during gastrulation for specifying neural crest
fate in fish and amphibians (Tribulo et al., 2003; Wilson
et al., 1997; Marchant et al., 1998; Barth et al., 1999;
Nguyen et al., 1998; Faure et al., 2000). During gastrula-
tion, neural crest features can be induced elsewhere in
the ectoderm of amphibians by manipulating BMP levels
in a context-dependent manner: In the epidermis, BMP in-
hibition induces snai2 expression (Steventon et al., 2009),
and the prospective neural plate domain shrinks after uni-
lateral injection of BMP4 mRNA deflects the snai2 expres-
sion domain medially (LaBonne and Bronner-Fraser,
1998). After this early stage of specification, BMP activity
at the neural plate border increases (Faure et al., 2002;
Nguyen et al., 1998; Steventon et al., 2009; Faure et al.,
2000), and the ability of the ectoderm to respond to BMP
changes; instead of repressing neural identity, BMP adopts
a dorsoventral patterning role for the neural tube (Timmer
et al., 2002).
Although it is clear that BMP activity affects the differen-
tiation of hPSCs into neural crest, the dynamics of this pro-
cess are still poorly understood. Specifically, the optimal
level of BMP activity required for neural crest induction isCell Reports j Vol. 9 j 1–10 j October 10, 2017 j ª 2017 The Authors. 1
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present in media components or produced endogenously
by the cells (Pera et al., 2004), and current methods of neu-
ral crest differentiation have multiple confounding factors
that make it difficult to assess the BMP environment of the
culture. These include the use of serum, non-recombinant
BSA, or other animal-derived products, as well as passaging
during the differentiation process. For these reasons, some
approaches require the inhibition of BMP (Lee et al., 2010;
Mica et al., 2013), whereas others have shown that BMP in-
hibition represses neural crest formation (Menendez et al.,
2011; Leung et al., 2016). It has been proposed that these
differences are due to a temporal effect necessitating BMP
inhibition early during differentiation (Mica et al., 2013).
However, BMP inhibition can repress neural crest fates
even when applied for just the first 24 hr of hPSC differen-
tiation, suggesting otherwise (Leung et al., 2016). The
development of a system without these caveats is key to a
better understanding of the differentiation process and a
requirement for translation of these protocols to the clinic.
A number of neurocristopathies are good candidates for cell
replacement therapies, such as Hirschsprung’s disease (Fat-
tahi et al., 2016; Workman et al., 2016), for which a fully
defined and xeno-free approach to generating the required
cells is essential.
In this study, we describe a fully defined and xeno-free
system for the differentiation of hPSCs into neural crest
and show that an optimum level of BMP activity is required
for neural crest induction, whereas higher or lower levels
lead to the induction of genes associated with non-neural
or neural identity, respectively. Finally, we show that varia-
tions in endogenous BMP production adversely affect neu-
ral crest differentiation efficiency between iterations of the
same protocol, and we present a method that controls for
this effect in multiple hPSC lines.RESULTS
To establish a fully defined protocol for neural crest differ-
entiation,wemodified the dual SMAD inhibition andWNT
activation approaches described previously (Lee et al.,
2010; Menendez et al., 2011) and developed an induction
medium (NCN2) that utilizes inhibition of TGFb and
GSK3 without the inhibition of BMP signaling, as this
was found to repress neural crest differentiation. To initiate
differentiation, human embryonic stem cells (hESCs;
WA09 or Shef6) or human induced pluripotent stem cells
(hiPSCs; Miff-1) were seeded at 10,000 cells cm2 onMatri-
gel in E6medium supplementedwith 10 mM g-27632. After
24 hr, the culture was switched to NCN2 medium contain-
ing N2 supplement, CHIR99021 (1.0 mM), and SB431542
(2.0 mM). In each cell line, sustained culture in NCN2 for2 Stem Cell Reports j Vol. 9 j 1–10 j October 10, 20177 days resulted in expression of the surface markers p75
and HNK-1 and the transcription factors TFAP2a, PAX3,
and SOX10, all of which are associated with neural crest
identity. In addition, expression of the stem cell marker
OCT4 (POU5F1) was lost (Figures 1A–1C). Sorting for cells
with high p75 expression (p75++) isolated most of the
SOX10 expression within the culture, confirming that
this surface marker can be used to purify putative neural
crest as has been shown before (Liu et al., 2012; Figure S1).
To confirm neural crest identity, we further tested differen-
tiation of cells sorted on the basis of GFP expression from a
SOX10 reporter cell line (H9:SOX10; Figure S2) into neural
crest-derived cell types. These included mesenchymal cells
that express CD73, CD90, and CD105 (Figure 2A) and
differentiate into osteocytes and chondrocytes (Figure 2B).
In addition, day 7 putative neural crest could be differenti-
ated into peripheral neurons expressing b-tubulin and pe-
ripherin (Figure 2C), as well as sensory neurons positive
for BRN3a and ISL1 (Figure 2D) and putative glial cells
expressing S100b and SOX10 (Figure 2E). Day 7 putative
neural crest also expressed the cranial marker ETS-1 (Fig-
ure 2F) and displayed a high level of motility in vitro (Fig-
ure 2G). Differentiation into melanocytes using the proto-
col described in Mica et al. (2013) was also attempted but
MITF expression was not observed.
Prolonged culture of hPSC-derived neural crest was
possible by detaching the cells at day 7 and culturing in
non-adherent conditions. In this environment, the cells
formed spheres that could be grown indefinitely. SOX10
expression was retained for at least 4 weeks while expres-
sion of PAX3 was lost, possibly indicating a reduction in
the proportion of neural crest precursors (Figure 2H).
When plated onto Matrigel, these spheres attach and cells
migrate out as if from an explanted neural tube (data not
shown).
The functional characteristics and marker expression of
cells generated using NCN2 are analogous to that of neural
crest, but the system is unpredictable. Cultures exhibited a
high level of variability in differentiation efficiency (p75++
cells ranging from 5% to 80%) in ostensibly identical con-
ditions. Instances of low differentiation efficiency often
coincided with increased expression of transcription fac-
tors associated with other ectodermal tissues, such as the
neural markers SOX2 and PAX6 or the non-neural markers
GATA2 and GATA3, at the expense of the neural crest
marker SOX10. Since BMP signaling plays a role in the
patterning of early ectoderm, while BMP inhibition has
a repressive effect in our system, we postulated that
variation in endogenous BMP signaling might be the
cause of the variability in differentiation efficiency. To
investigate this, we used recombinant BMP4 and noggin
to modulate BMP signaling during differentiation and
analyzed cell identity based on expression of ectodermal
Figure 1. Differentiation of hPSCs into Neural Crest
(A) Schematic of the neural crest differentiation protocol. Blue, E6 medium; orange, NCN2 induction medium.
(B) hESC Shef6 and H9 (WA09) and hiPSC Miff-1 upregulate p75 after 7 days in NCN2; expression is low in undifferentiated cells.
(C) Expression of TFAP2a, PAX3, and SOX10 at day 7 (qPCR). The stem cell marker OCT4 is repressed. Gene expression is presented relative to
initial undifferentiated hPSCs (RQ). Error bars represent SD. Data for each cell line is from a single experiment representing the potential
differentiation efficiency obtainable. Pooled data were not used because of reproducibility issues when using NCN2 alone as described and
addressed below.
Please cite this article in press as: Hackland et al., Top-Down Inhibition of BMP Signaling Enables Robust Induction of hPSCs Into Neural
Crest in Fully Defined, Xeno-free Conditions, Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.08.008markers: SOX2, PAX6, and PAX3 for neural; PAX3, SOX10,
and TFAP2a for neural crest; and TFAP2a, GATA2, and
GATA3 for non-neural. In addition, we used the reporter
line H9:SOX10 to provide a better assessment of differenti-
ation efficiency, as p75 is expressed in neural tissue as well
as neural crest.
A series of experiments were conducted in which paral-
lel cultures were subjected to different levels of BMP
signaling throughout differentiation. These experiments
were assessed retrospectively to determine if (1) instances
of low neural crest differentiation efficiency in NCN2
correlated with low/high endogenous BMP expression
levels and could be rescued by exogenous BMP modula-
tion in parallel cultures and (2) repeat iterations of differ-
entiation showed a requirement for different levels of
BMP4 or noggin for efficient neural crest differentiation.
These experiments revealed that peak differentiation effi-
ciency, as assessed by p75++ and GFP expression, could
occur under different exogenous BMP conditions (i.e.,
different levels of recombinant BMP4 or noggin in the
differentiation medium) between experiments. Data are
presented from two examples that exhibited different dif-
ferentiation efficiencies when in NCN2 medium alone,24% and 4% GFP positive for experiment 1 and 2, respec-
tively (Figure 3A). In experiment 1, a significantly higher
level of BMP4 expression was detected from day 0 to 4 of
differentiation than in experiment 2 (Figure 3B). This
disparity between the two experiments correlated with
higher levels of endogenous BMP4 protein detected in
the medium by ELISA on day 0 in experiment 1 (Fig-
ure 3C). In experiment 2, a parallel culture grown in
NCN2 with additional 1 ng mL1 BMP4 exhibited differ-
entiation efficiency equivalent to that of NCN2 alone in
experiment 1. In contrast to this, additional 1 ng mL1
BMP4 in experiment 1 reduced efficiency (Figure 3A).
In both cases, the efficiency in the presence of
2ng mL1 BMP4 was 0%, and the effect of noggin alone
was repressive. This is consistent with insufficient
BMP activity in the basal condition of experiment 2,
compared with experiment 1. This allows the addition
of recombinant BMP4 in experiment 2 to increase the
BMP activity into the range required for neural crest,
equivalent to the basal condition in experiment 1, result-
ing in neural crest induction. In either case, further addi-
tion of BMP4 appears to result in a level of BMP signaling
that is too high for neural crest induction.Stem Cell Reports j Vol. 9 j 1–10 j October 10, 2017 3
Figure 2. Analysis of hPSC-Derived Neural Crest
(A and B) Putative neural crest derived from H9:SOX10 and sorted for GFP expression (A) upregulates CD73, CD90, and CD105 in
mesenchymal growth conditions (see Experimental Procedures) and (B) can be differentiated into osteocytes and chondrocytes, stained
with Alizarin red and toluidine blue, respectively.
(C and D) H9:SOX10-derived neural crest in neural differentiation conditions are positive for peripherin and TUJ-1 in unsorted cells via
intermediate spheroid culture (C) and in sorted cells alongside sensory neural markers BRN3a and ISL1 (D).
(E) Expression of the glial markers SOX10 and S100b in neural crest derived from the iPSC line NB1.
(F) Expression of the cranial neural crest marker ETS-1 at day 7 of neural crest induction (Miff-1).
(G) In vitro, putative neural crest are highly motile; scratch ablation recolonized by GFP positive cells (arrow) within 16 hr (H9:SOX10).
(H) Sections of typical H9:SOX10-derived neural crest spheres after 4 weeks of non-adherent culture.
4 Stem Cell Reports j Vol. 9 j 1–10 j October 10, 2017
Please cite this article in press as: Hackland et al., Top-Down Inhibition of BMP Signaling Enables Robust Induction of hPSCs Into Neural
Crest in Fully Defined, Xeno-free Conditions, Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.08.008
Figure 3. Endogenous BMP Expression Affects Neural Crest Differentiation Efficiency
(A) Day 7 flow cytometric analysis showing p75 and GFP expression in parallel cultures with varying concentrations of BMP4 and/or noggin
(H9:SOX10). In the absence of these factors, differentiation efficiency (p75++ GFP+) was higher in experiment 1 than in experiment 2.
1 ng mL1 BMP4 promoted neural crest in experiment 2 but repressed neural crest in experiment 1.
(B) qPCR shows significantly higher BMP4 expression in experiment 1 than in experiment 2 between days 0 and 4 without exogenous BMP4
or noggin.
(C) BMP4 protein (ELISA) in the medium at day 0 was higher in experiment 1 without exogenous BMP4 or noggin.
(D) Day 7 gene expression (qPCR) in the presence of 0, 1, and 2 ng mL1 exogenous BMP4 without noggin (experiment 2). A changing
pattern consistent with a neural, neural crest, and non-neural identity, respectively, is observed. Colored bars denote tissue association.
Error bars represent SD of technical replicates within corresponding experiment. All data shown represent neural crest induction using the
cell line H9:SOX10.
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level of BMP,which is confounded in different experiments
due to variation in the endogenous production of BMP by
hPSCcultures, perhaps causedbyvariable anduncontrolled
spontaneous differentiation. Due to the difficulty in pre-dicting the level of BMP4 expression in hPSC cultures prior
to neural crest differentiation, we instead designed a system
to control the BMP signaling environment of the cultures
irrespective of the level of endogenous BMP production.
This system, termed ‘‘top-down inhibition’’ (TDi), involvesStem Cell Reports j Vol. 9 j 1–10 j October 10, 2017 5
Figure 4. Top-Down Inhibition Controlling for the Effect of Variable Endogenous BMP Expression Using Agonist Saturation
(A) TDi schematic. Saturating with BMP4 means any variation in BMP levels occur outside of the cellular dose response; DMH1 attenuates
the positive BMP signal.
(B) Flow cytometric analysis GFP expression in H9:SOX10 at day 7 in TDi or medium containing either DMH1 or BMP4 alone.
(C) Presence of phospho-SMAD1/5/9 after switching to differentiation medium.
(legend continued on next page)
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neously attenuating this signal using the BMP type 1 recep-
tor inhibitor, DMH1 (Figure 4A). By addinghigh levels of re-
combinant BMP4, the range of BMP activity within which
cells can respond is exceeded, and any change in endoge-
nous BMP4 expression no longer results in a dose response
from the culture. Application of DMH1 then allows the
optimal BMP activity required for neural crest differentia-
tion to be achieved without the induction of genes associ-
ated with non-neural ectoderm (Figures 4B, 4C, 4F, and
4G). A saturating amount of BMP4 (15 ng mL1) and an
optimum amount of DMH1 (1.0 mM) were found by titra-
tion of these factors against one another. Use of DMH1 or
BMP4 in the medium alone results in failure to induce
SOX10 expression (Figures 4B, 4F, and 4G). In the case
of DMH1, the neural-associated transcription factors
PAX3 and PAX6 are still expressed within the culture, as
is SOX2 (at a higher level in a smaller proportion of the
cells). In the case of BMP4, TFAP2a is instead retained,
and expression of the non-neural ectoderm-markers
GATA2 and GATA3 is induced. Balancing both BMP4 and
DMH1 creates an intermediate effect resulting in a neural
plate border fate that is consistent across different hPSC
lines (Figure S3).
Changing the level of BMP4 in TDi medium between 13
and 17 ng mL1 did not significantly change the propor-
tion of cells inducing SOX10 expression (as reported by
GFP), suggesting that 15 ng mL1 is enough to saturate
the system (Figure 4D). Western blot analysis shows that
an hour after switching from seeding medium into TDi,
levels of phospho-SMAD1/5/9 increased to a level that
was less than in the presence of BMP4 alone but more
than in the presence of DMH1 alone and NCN2 without
treatment in this case (Figure 4C). These data also show
that phospho-SMAD1/5/9 levels decrease with time despite
the medium remaining unchanged. Most strikingly, with
the use of TDi, we have been able to greatly reduce the vari-
ation exhibited between iterations of neural crest differen-
tiation and thus improve the reproducibility of our experi-
ments in all three cell lines tested (Figures 4E and S3).
Differentiation of hPSCs into neural crest using TDi was
also achieved on the xeno-free matrices Laminin 521 and
vitronectin (Figure S4).(D) Changes in the BMP4 concentration of TDi medium (15 ± 2 ng mL
(E) TDi significantly increases the reproducibility of differentiation. Pr
and the first six results using TDi (H9:SOX10 within 6 months).
(F) Ectodermal gene expression at day 7 in TDi or medium containing D
ectodermal tissue is marked below. Data were pooled from three inde
(G) Expression of SOX10, PAX3, SOX2, PAX6, and GFP in H9:SOX10 at da
bars represent 100 mM. Error bars represent SD.
*p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001. ns, not sig
Shef6 (hESC) and Miff-1 (hiPSC), refer to Figure S3.DISCUSSION
In this study, we developed a fully defined and xeno-free
differentiation medium that can be used to generate
putative neural crest from hPSCs in a robust manner. This
medium can be used in conjunction with Laminin 521 or
vitronectin as a substrate, allowing fully xeno-free produc-
tion of neural crest for clinical applications and for further
study into neural crest induction from hPSCs. Cells gener-
ated in this way can bemaintained in non-adherent condi-
tions in a manner that may allow for scaling up of neural
crest cell production. The efficacy of our protocol is sup-
ported by the expression of neural crest-associated genes
and surface markers in multiple cell lines, as well as func-
tional analysis of differentiation capacity and motility.
Although it is possible that a small proportion of the cells
in culture at day 7 may be either mesenchymal or
SOX10-positive cell types that are not neural crest, the ma-
jority of these cells exhibit marker expression (such as co-
expression of SOX10 with PAX3 or PAX7) and function
that is consistent with neural crest. Restriction of SOX10
and PAX6 expression to p75++ and p75+ populations,
respectively, indicates that cells sorted on the basis of
SOX10 induction for peripheral neural differentiation
are unlikely to contain neurectoderm precursors. The pos-
sibility that this system restricts further differentiation
into the melanocyte lineage cannot be ruled out, as MITF
positive cells could not be generated by following the pro-
tocol described byMica et al. (2013), althoughmelanocytes
were not successfully generated from differentiation car-
ried out in NCN2 either, so it is unlikely that this is caused
by BMP saturation.
Intermediate levels of BMP signaling play a key inductive
role in neural crest formation in vivo, but to date there has
not been a consensus on the required level of BMP activity
for neural crest differentiation of hPSCs in vitro. The results
presented here, from work in a fully defined system, imply
that intermediate levels of BMP activity are also required
for human neural crest induction in vitro, and that levels
outside of this narrow range lead to increased expression
of transcription factors associated with other ectodermal
tissues at the expense of those associated with neural crest.
It is likely that in culture conditions that may be rich in1) do not result in a significant change in neural crest efficiency.
esented is neural crest efficiency from the last six results using NCN2
MH1 or BMP4 alone (qPCR). Association of transcription factors with
pendent experiments.
y 7 in TDi or in medium containing either DMH1 or BMP4 alone. Scale
nificant. All data shown uses H9:SOX10. For supporting data using
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would be required early during differentiation to prevent
induction of a non-neural ectoderm fate. This reconciles
the apparently conflicting published approaches to BMP
signaling in neural crest differentiation from hPSCs. It is
only in a fully defined system that the required signals
for induction can be dissected, although endogenously
produced growth factors can still be a confounding factor
in such investigations. The inclusion of BSAmay also effect
the signaling environment during neural crest differentia-
tion. BSA acts as a carrier protein facilitating uptake of
some growth factors, and other ligands, by cells in culture
(Francis, 2010). BSA purified from bovine serum may
already be bound to biologically active factors that could
affect differentiation or affect the activity of other factors
added to the culture medium. Inclusion of BSA may also
decrease the potency of the smallmolecules used for neural
crest differentiation. Two other published systems for
neural crest differentiation from hPSCs, both of which
involve the use of BSA, require a 5-fold and 10-fold higher
concentration of CHIR99021 and SB431542, respectively
(Menendez et al., 2011; Leung et al., 2016).
In the development of this system, we showed that
endogenous BMP expression can be sufficient to direct
hPSCs toward an neural crest fate in an environment that
is devoid of external BMP modulation (using NCN2 me-
dium). However, we encountered difficulties generating
neural crest with reproducible differentiation efficiencies
while using this basic system. By using TDi, we were able
to significantly reduce this variability, presumably by stabi-
lizing the level of BMP activity between experiments. It
should be noted that recombinant BMP4 from different
sources may vary in activity and should therefore be
titrated in the presence of 1 mMDMH1 to assess the satura-
tion point on the basis of efficient neural crest induction.
The TDi approach also has the advantage that it controls
for the effect of endogenously produced BMP accumula-
tion in the medium during periods between media chang-
ing. A caveat to this approach is that flooding the system
with recombinant BMP4 will change the ratio of BMP4 to
other BMP ligands, although this does not appear to
adversely affect neural crest induction. The observation
that phospho-SMAD1/5/9 peaks 1 hr after application of
differentiation medium, before decreasing, despite the me-
dium remaining unchanged, is consistent with observa-
tions of phospho-SMAD4 induction and turnover in
response to TGF-b signaling (Sorre et al., 2014).
TDi could be used in any system where an attenuated
signal is required and an agonist and antagonist are avail-
able that act extracellularly and intracellularly, respec-
tively, with a high level of specificity. The small molecule
DMH1 is ideal for this as it acts on the BMP type 1 receptor
(Hao et al., 2010), as opposed to antagonists such as noggin8 Stem Cell Reports j Vol. 9 j 1–10 j October 10, 2017that bind BMP ligands directly (Groppe et al., 2002). If such
molecules are not available, an alternative ‘‘baseline activa-
tion’’ approach would be to saturate instead with an antag-
onist that binds directly to any endogenously produced
ligand in the medium, used in conjunction with a small
molecule that activates the signaling pathway internally
(examples for the WNT pathway could be DKK1 and
CHIR99021, respectively). Approaches such as these would
be particularly useful when recapitulating the concentra-
tion-dependent effects of morphogens or when endoge-
nous signal expression is a confounding factor. Although
using TDi greatly reduced the variability observed between
iterations of neural crest differentiation and showed robust
differentiation in all lines tested, some variability still ex-
ists, raising the possibility that endogenous expression of
other signals, such as WNT, may also be having an effect.
Like BMP, titration of WNT3a or CHIR99021 shows an op-
timum level of WNT activity for neural crest induction
(data not shown). This raises the possibility that endoge-
nous production of WNT ligands may also adversely affect
differentiation. Finally, it is to be noted that heterogeneity
still persists in neural crest differentiation cultures and that
although some of the cells that are SOX10 negative on day
7 may still be in a precursor stage, occasional rosette-like
structures and other morphological characteristics within
the culture suggest that others have more in common
with neural or possibly non-neural ectoderm (Figures 4G
and S3B). Thismay be due to different signalingmicroenvi-
ronments within the culture or cells within the original
hPSC population that exhibit bias toward particular fates.
Conclusion
Here, we present a fully defined and xeno-free system for
neural crest induction from hPSCs. We identify endoge-
nous BMP production as a major source of variability in
neural crest differentiation efficiency and describe a
method that controls this variability, the theory of which
could be applied in other protocols for the differentiation
of hPSCs.EXPERIMENTAL PROCEDURES
Pluripotent Stem Cell Culture
All cell lines were cultured in mTESR on Matrigel. See Supple-
mental Experimental Procedures for more details.
Neural Crest Differentiation
Neural crest differentiation was achieved as described in the
Results.
Non-adherent Culture of Neural Crest
Day 7 cultures were detached using Accutase (Gibco, A11105-01;
7 min); 50,000–100,000 cells were added per well in 96-well plates
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Crest in Fully Defined, Xeno-free Conditions, Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.08.008coated with 1% agarose in N2 supplemented DMEM F12 contain-
ing ROCK inhibitor (g-27632) for the first 24 hr and with half
media changes every 2–3 days.
Immunofluorescence and Flow Cytofluorimetry
For details including a list of antibodies, see Supplemental Experi-
mental Procedures.
qPCR
The Taqman gene expression assay system was used for all qPCR.
For details including a list of assay mixes, see Supplemental Exper-
imental Procedures.
Terminal Differentiation of Neural Crest
Terminal differentiation into mesectodermal and neural lineages
was performed using kits from STEMCELLTechnologies and proto-
cols published by the Studer lab (Lee et al., 2010; Chambers et al.,
2012), respectively. For details, see Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2017.08.008.
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